Serotonin News and Research

Latest Serotonin News and Research

How the gut microbiome contributes to schizophrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

19 Oct 2023

How do different organ microbiomes influence neuropsychiatric disorders?

Scientists review existing literature to understand how the microbiome influences neuropsychiatric disorders.

19 Oct 2023

Study links long COVID to gut inflammation and serotonin deficiency

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

16 Oct 2023

Are migraines linked to gut health and chronic non-communicable diseases?

The Links Between Migraines, Gut Health, and Chronic Non-Communicable Diseases (CNCDs).

13 Oct 2023

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Researchers in neuropsychopharmacology challenge conventional wisdom about antidepressants' actions, revealing significant intracellular activity that influences their effectiveness. Utilizing advanced technologies, the study prompts a reevaluation of drug targeting and mechanisms, opening new avenues for treating depression.

12 Oct 2023

Research explains the reason behind delay in therapeutic action of antidepressants

SSRI antidepressants normally take a few weeks before any showing mental health benefits, but how come it takes so long? Now a study from a group of clinicians and scientists provides the first human evidence that this is due to physical changes in the brain leading to greater brain plasticity developing over the first few weeks of SSRI intake.

9 Oct 2023

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Intrusive thoughts, involuntary repetition of undesirable gestures and behaviors combined with high anxiety... Obsessive-compulsive disorder (OCD), a disabling condition, affects around 2% of the population, regardless of age.

9 Oct 2023

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Both severe depression and treatment-resistant depression are common. Up to one third of patients do not respond to conventional therapy with antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).

5 Oct 2023

Esketamine outperforms one of the standard drugs for treatment-resistant major depression

A major clinical trial shows that the drug, esketamine, one of the two main forms of ketamine, outperforms one of the standard treatments for treatment-resistant major depression.

4 Oct 2023

Could a Poria cocos extract be the key to conquering insomnia?

The study reveals that Poria cocos extract significantly improves sleep quality in insomniacs, increasing total sleep time and enhancing REM sleep duration. While promising, further investigations are needed to validate these findings and explore the effects of other active compounds within P. cocos.

3 Oct 2023

Transforming postpartum depression treatment with neurosteroids

A new study in Neuropsychopharmacology delves into the mechanisms of action of brexanolone, the first FDA-approved, rapid-acting antidepressant specifically for postpartum depression (PPD). The research highlights brexanolone's potential anti-inflammatory effects and its impact on GABAA receptors, offering insights into its efficacy and suggesting avenues for further study.

19 Sep 2023

MDMA-assisted therapy reduces PTSD symptoms dramatically

New study shows MDMA-assisted therapy significantly reduces symptoms in individuals with moderate to severe PTSD, outperforming traditional therapy and medications. The study, covering multiple sites in the U.S. and Israel, indicates that while effective, further research is needed to explore potential side effects and effectiveness across diverse groups.

17 Sep 2023

New genetic test reveals a person’s predisposition to happiness

Your happiness levels aren't only based on external events. Genome testing can reveal how happy and optimistic you are predisposed to be. A leading testing expert reveals how variations of a key gene, CNR1, may have a significant impact on your level of happiness.

15 Sep 2023

Can fluctuating reproductive hormone levels cause mental health conditions?

The association between mental health and fluctuations in reproductive hormone levels.

11 Sep 2023

Rethinking menopause: Experts call for individualized treatment and more research

A comprehensive review in the journal Cell provides an in-depth look at the biology, clinical outcomes, and treatment options for menopause, including the effects of hormonal changes on metabolic and cognitive functions. The article also discusses various therapeutic interventions, from hormone therapy to alternative medicines, and their efficacy in managing menopausal symptoms.

7 Sep 2023

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

In a recent review published in Cell, a group of authors delved into the complexities of menopause, assessed its global impacts on health, and evaluated the effectiveness and safety of current treatments, emphasizing the importance of further research.

6 Sep 2023

Research reveals 71% of men in the UK are struggling to sleep through the night

New research, from men’s healthcare company Numan, suggests there is a sleep crisis among UK men with 71% of men surveyed struggling to sleep through the night.

4 Sep 2023

Smoking linked to increased risk of depression, bipolar disorder

Most of us know that smoking is unhealthy. Cigarette packets display shocking picture warnings of diseased lungs and rotting teeth. And we often hear in the media about how smoking can cause all sorts of cancer.

30 Aug 2023

AI-powered patient triage platform predicts COVID-19 severity and length of hospitalization

A team of researchers from Yale University and other institutions globally has developed an innovative patient triage platform powered by artificial intelligence (AI) that the researchers say is capable of predicting patient disease severity and length of hospitalization during a viral outbreak.

29 Aug 2023

GABA-modulating treatments could help tackle cognitive, affective symptoms associated with depression

Depression is a complex condition correlated with multiple differences in brain function and mechanisms. A new paper spanning known data about the neurotransmitter GABA and its principal receptors showcases evidence of the receptors' importance in depression and potential as therapeutic targets.

3 Aug 2023

Serotonin News and Research

Latest Serotonin News and Research

How the gut microbiome contributes to schizophrenia

How do different organ microbiomes influence neuropsychiatric disorders?

Study links long COVID to gut inflammation and serotonin deficiency

Are migraines linked to gut health and chronic non-communicable diseases?

Intracellular journey: The penetration of antidepressants into cells, organelles, and membranes

Research explains the reason behind delay in therapeutic action of antidepressants

Psychedelics may increase neuroplasticity by promoting the remodeling of synaptic connections

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Esketamine outperforms one of the standard drugs for treatment-resistant major depression

Could a Poria cocos extract be the key to conquering insomnia?

Transforming postpartum depression treatment with neurosteroids

MDMA-assisted therapy reduces PTSD symptoms dramatically

New genetic test reveals a person’s predisposition to happiness

Can fluctuating reproductive hormone levels cause mental health conditions?

Rethinking menopause: Experts call for individualized treatment and more research

World-renowned menopause experts summarize the state of menopause knowledge and advocate for further research

Research reveals 71% of men in the UK are struggling to sleep through the night

Smoking linked to increased risk of depression, bipolar disorder

AI-powered patient triage platform predicts COVID-19 severity and length of hospitalization

GABA-modulating treatments could help tackle cognitive, affective symptoms associated with depression

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Serotonin News and Research

Latest Serotonin News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in